60 likes | 73 Views
Gemcitabine HCL Market grows with favourable regulatory scenario for large molecule injectables (biosimilars), high demand for cost-effective generic formulations over branded ones, and government support to increase the utilization of generic injectable products.
E N D
©2019 Transparency Market Research, All Rights Reserved Gemcitabine HCL Market Type: Branded and Generic; Application: Pancreatic Cancer, Breast Cancer, Ovarian Cancer, Non-small-cell Lung Carcinoma (NSCLC), and Others; End-user: Hospitals, Cancer Centers, and Others Forecast From 2019 - 2027 ©2019 Transparency Market Research, All Rights Reserved
©2019 Transparency Market Research, All Rights Reserved Table of Content Sr. No. Content Chapter1 Preface Chapter 2 Assumptions and Research Methodology Chapter 3 Executive Summary: Global Blood Pressure Cuffs Market Chapter 4 Market Overview Chapter 5 Key Insights Chapter 6 Global Blood Pressure Cuffs Market Analysis and Forecast, by Usage Chapter 7 Global Blood Pressure Cuffs Market Analysis and Forecast, by Product Type Chapter 8 Global Blood Pressure Cuffs Market Analysis and Forecast, by End User Chapter 9 Global Blood Pressure Cuffs Market Analysis and Forecast, by Region Chapter 10 North America Blood Pressure Cuffs Market Analysis and Forecast Chapter 11 Europe Blood Pressure Cuffs Market Analysis and Forecast Chapter 12 Asia Pacific Blood Pressure Cuffs Market Analysis and Forecast Chapter 13 Latin America Blood Pressure Cuffs Market Analysis and Forecast Chapter 14 Middle East & Africa Blood Pressure Cuffs Market Analysis and Forecast Chapter 15 Competition Landscape
©2019 Transparency Market Research, All Rights Reserved Gemcitabine HCL Market: Snapshot • Gemcitabine HCL Market grows with favourable regulatory scenario for large molecule injectables (biosimilars), high demand for cost-effective generic formulations over branded ones, and government support to increase the utilization of generic injectable products. • Generic Segment Expected to Grow at a Rapid Pace in the Gemcitabine HCl Market • The gemcitabine HCl market report offers exhaustive segmentation of the global market based on type, application, and end user. ©2019 Transparency Market Research, All Rights Reserved
©2019 Transparency Market Research, All Rights Reserved ©2019 Transparency Market Research, All Rights Reserved
©2019 Transparency Market Research, All Rights Reserved Reports Highlights Global gemcitabine HCl market for the forecast period of 2019 to 2027. According to the report, the global gemcitabine HCl market is projected to reach a value of over US$ 900 Mn by 2027, expanding at a CAGR of nearly 7% from 2019 to 2027. • • Key Player – Teva Pharmaceutical Industries Ltd., Lupin Ltd., Sanofi, Biocon. Dr. Reddy’s Laboratories, Sun Pharmaceutical Industries Ltd., Mylan N.V., GlaxoSmithKline plc, and AstraZeneca plc. Request Sample ©2019 Transparency Market Research, All Rights Reserved
©2019 Transparency Market Research, All Rights Reserved To know more about us, please visit our website: www.transparencymarketresearch.com For sales queries or new topics email us on: sales@transparencymarketresearch.com For other queries contact: 90 State Street, Albany NY – 12207, United States Tel: +1-518-618-1030 T H A N K Y O U